Cambrex has posted a 55 per cent drop in operating profit in the first quarter, underpinned by the timing of orders, disruption to a customer’s supply chain and lower pricing of certain generic APIs.
West Pharmaceutical Services reported strong fourth quarter results, underpinned by demand for H1N1 components, but still posted a dip in operating income for its 2009 financial year.
Cardinal Health has implemented a series of business reshuffles and
cost cutting measures in the hope of pulling itself out of poor
profitability after disappointing third quarter results.
DSM of the Netherlands saw its operating profit slump 23 per cent
to €294 million last year, hit by higher raw material costs and
declining sales of its life sciences products.
DSM reports a disappointing set of second quarter results and says
it is unlikely to meet its 2002 operating profit level this year;
the group blames weaker demand for its products and negative
currency factors. Restructuring drive...